FANDOM


 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
'''Hargreave-Rasch Biomedical''' is a company existing during and long before the [[Crysis 2]] main storyline. As its name suggests, it is a biomedical company that was founded by [[Jacob Hargreave]] (death 2023) and [[Karl Ernst Rasch]] (alive as of August 2023).
+
'''Hargreave-Rasch Biomedical''' is a biomedical company that was founded by [[Jacob Hargreave]] and [[Karl Ernst Rasch]]. The company was founded mainly in order to serve as the front stage of its the daughter company, [[CryNet]].
   
The Company was founded mainly in order to serve as the front stage of what Crynet, the daughter company, was doing. Through the company, Jacob Hargreave and Karl Rasch developed the [[Nanosuit]] and [[Nanosuit 2]] in order to face the impending [[Ceph]] invasion. Hargreave in particular knew about the invasion and was planing to wear the nanosuit himself to face the Ceph but was rendered inable due to age.
+
Through the company, Jacob Hargreave and Karl Rasch developed the [[CryNet Nanosuit|Nanosuit]] and [[CryNet Nanosuit 2|Nanosuit 2]] in order to face the impending [[Ceph]] invasion. Hargreave in particular knew about the invasion and was planning to wear the nanosuit himself to face the Ceph, but was rendered unable due to various complications.
 
[[Category:Crysis 2]]
 
[[Category:Crysis 2]]
[[Category:Crysis 2 Characters]]
+
[[Category:Companies]]

Latest revision as of 10:02, January 30, 2020

Hargreave-Rasch Biomedical is a biomedical company that was founded by Jacob Hargreave and Karl Ernst Rasch. The company was founded mainly in order to serve as the front stage of its the daughter company, CryNet.

Through the company, Jacob Hargreave and Karl Rasch developed the Nanosuit and Nanosuit 2 in order to face the impending Ceph invasion. Hargreave in particular knew about the invasion and was planning to wear the nanosuit himself to face the Ceph, but was rendered unable due to various complications.

Community content is available under CC-BY-SA unless otherwise noted.